GEA OptiPartner combines advanced digital technology with decades of process expertise to optimize spray drying plants for ...

Now, in a five-page letter sent by Jay Clayton, U.S. Attorney for the Southern District of New York, to U.S. District Judge ...

Autolus Therapeutics, a commercial-stage biopharmaceutical company, has announced plans to assess the feasibility of Cellares ...

In a non-deterministic, AI-driven architecture, if your security strategy is trying to “catch up,” you’ve already lost.

MOST of the P33-billion budget earmarked for farm-to-market roads (FMRs) in 2026 will bolster the production of key farm ...

The Cellares Cell Shuttle platform was the first to receive the FDA’s Advanced Manufacturing Technology (AMT) designation, which offers partners additional touchpoints and priority review mechanisms ...

Next-generation automation is closing the gap between curative science and real-world demand, enabling faster development, ...

Transcenta Therapeutics, a global biopharmaceutical company with capabilities in discovery, research, development and ...

Autolus will evaluate Cellares' fully automated, high-throughput manufacturing platform in preparation for expansion into new indications Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage ...

Lawmakers are moving to cut funding but rejecting severe reductions sought by the White House to energy and environment ...

President Donald Trump's use of military force to capture Venezuela's president Nicolás Maduro is sure to take center stage ...